The first Internet management expert guidance on common adverse drug reactions of liver cancer is released

A few days ago, China's first "Expert Guidance on the Internet Management of Common Drug Treatment-Related Adverse Reactions for Liver Cancer Patients" (hereinafter referred to as the "Guiding Opinions") was formally published in the core journal of China's science and technology "Electronic Journal of Liver Cancer"
.

The "Guiding Opinions" are composed of the Multidisciplinary Collaborative Group of Gastrointestinal Tumors, Cancer Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College, China Healthcare International Exchange Promotion Association Liver Oncology Branch, China Healthcare International Exchange Promotion Association International Education and Training Branch, China Healthcare International Exchange The Health Science Branch of the Promotion Association participated together, and the formulation was completed with the support of the Medical Federation

According to the latest global cancer burden data released by the International Agency for Research on Cancer (IARC) of the World Health Organization in 2020, there are 900,000 new cases of liver cancer in the world in 2020, and China accounts for 45.
6%; and 830,000 cases of deaths, China accounts for 47%
.

At present, clinical methods for the treatment of liver cancer mainly include surgical resection, local ablation, interventional therapy, radiotherapy, liver transplantation, etc.

Data shows that in the process of anti-tumor treatment, a variety of examination methods and therapeutic drugs can cause kidney damage.
Among them, the proportion of acute kidney injury in liver cancer patients is about 33%, but through early intervention, renal function can be partially or completely restored
.

The introduction of the "Guiding Opinions" has effectively alleviated the pain points of out-of-hospital intervention

At the same time, because the adverse reactions involved in the "Guiding Opinions" are easy to identify and monitor, the Internet online management team, patients and their caregivers can also directly refer to it, which is conducive to the early prevention and timely intervention of the corresponding symptoms, which breaks the existing The guidelines and consensus content only apply to the limitations of professional medical staff, which greatly expands the scope of use
.

In addition, although the starting point of the "Guiding Opinions" is the common treatment drugs for liver cancer, it is also applicable to the management of adverse reactions caused by most common tumor drug treatments

Cai Jianqiang, deputy dean of the Cancer Hospital of the Chinese Academy of Medical Sciences, said: “With the advancement of medicine, the treatment of clinical malignant tumors has entered the stage of systematic treatment in which multiple treatment methods are combined and multiple disciplines are involved
.

Individual experience and needs in the treatment process have formulated a detailed and standardized out-of-hospital management process

In the process of receiving systematic treatment, cancer patients have a limited hospital stay.
After discharge, with limited medical information, how to obtain standardized, timely, effective and continuous management is an urgent need for patients and their families to be met
.

The Medical Federation began to try out-of-hospital management of cancer patients in December 2019, and officially launched the “Out-of-hospital Internet follow-up management project for cancer patients” in October 2020, covering common cancer types such as liver cancer, lung cancer, gastric cancer, breast cancer, and neuroendocrine tumors
.

The "Guiding Opinions" issued this time are the first results of the project

Liu Chunmei, vice president of the Medical Federation, said: “In the future, more cancer patients will live with the disease.
How to make these patients get convenient, timely and standardized management outside the hospital, improve their quality of life, and prolong their survival time is a medical The goal of Lianlian's exploration in the oncology discipline
.

It is a great honor to be deeply involved in the formulation of the "Guiding Opinions", and to share the thinking and accumulated clinical experience of the Medical Federation in the on-line management of oncology, especially the online disease management process and standard setting work.